Abstract
was transected distal to the papilla and beyond the duodenojejunal flexure and a side-to-side duodenojejunal anastomosis was formed. Patients were identified from a prospectively maintained database and outcomes determined from digital health records with a dataset including demographics, co-morbidities, mode of presentation, preoperative imaging and assessment, nutritional support needs, technical operative details, blood transfusion requirements, length of stay, pathology including lymph node yield and lymph node involvement, length of follow-up, complications and outcomes. Related published literature was also reviewed.
RESULTS
Twenty-four patients had surgery with the intent of performing PPDD from 2003 to 2016. Nineteen underwent PPDD successfully. Two patients planned for PPDD proceeded to formal pancreaticoduodenectomy (PD) while three had unresectable disease. Median post-operative follow-up was 32 mo. Pathologies resected included duodenal adenocarcinoma (n = 6), adenomas (n = 5), gastrointestinal stromal tumours (n = 4) and lipoma, bleeding duodenal diverticulum, locally advanced colonic adenocarcinoma and extrinsic compression (n = 1 each). Median postoperative length of stay (LOS) was 8 d and morbidity was low [pain and nausea/vomiting (n = 2), anastomotic stricture (n = 1), pneumonia (n = 1), and overwhelming postsplenectomy sepsis (n = 1, asplenic patient)]. PPDD was associated with a significantly shorter LOS than
INTRODUCTION
The duodenum gives rise to more neoplasia, and possibly pathology in general, per unit length, than does any other part of the small bowel [1, 2] . The retroperitoneal position of the duodenum, its shared blood supply with the pancreas, and its relationship with the ampulla of Vater and the superior mesenteric vessels ensure that any duodenal resection is potentially a major undertaking. Pancreatico duodenectomy (PD) constitutes the mainstay of surgical treatment of duodenal lesions [3] and up to 10% of PDs are undertaken for lesions that actually arise in the duodenum [4] . However, PD is associated with significant morbidity and mortality, which is due in part to pancreatic resection and anastomosis. Moreover, it is likely that the actual risks associated with PD are widely underestimated [5] . Duodenal resection with pancreas preservation is possible and has been used in the treatment of a range of duodenal conditions. Pancreas preserving total duodenectomy is an option for the treatment of diffuse noninvasive mucosal disease such as FAP associated polyposis [6, 7] whilst pancreas preserving distal duodenectomy (PPDD) has been described in the treatment of a range of benign and malignant lesions arising distal to the papilla complex [8, 9] . We describe how we perform a PPDD and present the longterm results of a series of 19 patients who underwent the procedure in a single centre for a variety of pathologies over a 14year period and also review the relevant literature.
MATERIALS AND METHODS

Preoperative investigations and preparation
This procedure is usually undertaken in an elective or scheduled capacity for patients with infrapapillary conditions that, in the opinion of the multidisciplinary team, warrant surgical resection. Criteria include M0 duodenal adenocarcinoma; large adenomata or those in positions that prevent effective endoscopic mucosal resection; and gastrointestinal stromal tumours. Patients routinely undergo multislice pancreas pro tocol computed tomography (CT) with occasional fluoroscopic investigations. Most have one or more modalities of endoscopic investigation. Poor nutritional status at presentation is considered an indication for nasojejunal feeding which is commenced 714 d preoperatively. Representative CT and endoscopic findings are shown in Figures 13 . The relationship of the tumour or lesion to the ampulla of Vater on preoperative endoscopy or CT is vital in determining the feasibility of offering the patient a PPDD. Nevertheless, the procedure should only be undertaken in an institution with expertise and facilities to perform a PD, as a small number of patients will not be suitable for a PPDD on surgical exploration because of close proximity of a malignant pathology to the ampulla or involvement of the pancreas by the malignant process. This should be considered in the consent process and we usually obtain consent to perform a PPDD with a view to proceed to a PD or perform a bypass procedure in the event of unresectability.
Operative technique
Arterial, central venous, epidural and bladder cathe terisations are performed for monitoring and pain relief. Flowguided intraoperative fluid therapy is used. In cases where there is concern regarding the proximity of the lesion to the ampulla, their relationship is confirmed intraoperatively with side viewing duodenoscopy. A transverse upper abdominal incision with appropriate fixed table retraction is used. The key operative steps are shown in Figure 4 Operative technique. After wide Kocherisation (A) the papilla and lesion are palpated. For benign pathology close to the papilla, the ampullary complex can be further protected by cannulation (B). The proximal jejunum is transected (C), the distal duodenum taken off its short vessels and the resection is completed (D). Reconstruction is by a retrocolic isoperistaltic side-to-side duodenojejunostomy (E).
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rotation (CattellBraasch manoeuver) [10] . Resectability is determined by excluding involvement of the pan creas and peripancreatic vessels and by confirming macroscopic proximal clearance of at least 10 mm with preservation of the major papilla complex. Macroscopic nodal and distant metastatic disease are also excluded. Frozen section biopsies are taken when necessary. After confirming resectability, the proximal jejunum is transected with a transverse linear cutting stapler and its mesentery, along with the ligament of Treitz and the peritoneal attachments of the duodenojejunal junction, are divided to permit delivery of the proximal jejunum behind the superior mesenteric vessels into the supracolic compartment. The third part of the duodenum (D3) and distal second part (D2) are then separated from the pancreatic head and uncinate process. The mobile, devascularised distal duodenum is then excised, again with linear stapler. For benign lesions close to the papilla, the latter is cannulated with a 4F infant feeding tube via a duodenotomy to facilitate proximal transection with preservation of the ampullary complex. PD is undertaken if the lesion involved to papilla. The proximal, blind end of jejunum is delivered through a window in the transverse mesocolon to permit a sutured sidetoside isoperistaltic duodeno jejunostomy, which is performed with 30 or 40 polydioxanone (PDS ® II, Ethicon, Edinburgh, United Kingdom) sutures in a single continuous layer. In cases assessed at risk of malnutrition or anticipated delayed gastric emptying, as in patients with preoperative gastric outlet obstruction, a fine bore nasojejunal feeding tube is placed across the anastomosis for postoperative feeding. A cholecystectomy is performed if the gallbladder is still in situ. A peritoneal drain is placed selectively if there is of a perceived risk of postoperative pancreatic fistulation following dissection on or close to the pancreas.
Postoperative management
Postoperative care is initially in a surgical high de pendency unit and has, in recent years, proceeded according to enhanced recovery after surgery (ERAS) principles [11] . Somatostatin analogues are not used routinely. The peritoneal drain, if used, is removed on the third postoperative day provided fluid amylase does not exceed three times serum amylase and there is no evidence of enteric content.
RESULTS
All patients undergoing PPDD within a large teaching hospital were identified using a prospectively maintained database and crosschecked against a hospital database of pathology specimens. Electronic healthcare records were reviewed for relevant in formation.
Between 2003 and 2016, 24 patients were explored with the intention of performing PPDD. In 3 patients, malignant involvement of the superior mesenteric artery precluded resection and palliative gastroenterostomy was undertaken. Two patients had intraoperative findings that necessitated PD, as the malignant process was close to the papilla and adequate resection margins could not have been obtained without a PD. Thus, 19 patients proceeded to PPDD. Median Charlson comorbidity index was 4 (range 06). Patient characteristics and modes of presentation and are shown in Table 1 . Either of two surgeons (DNL, AJB) oversaw each operation.
All 
DISCUSSION
In our experience, PPDD provides a valuable surgical treatment for a range of infrapapillary pathologies, which were in the most part neoplastic, including duodenal adenocarcinomas (n = 6, 32%), adenomas (n = 5, 26%) and gastrointestinal stromal tumours (n = 4, 21%).
PPDD avoids the potential complications associated with a pancreaticoenteric anastomosis. Although the infrequency of PPDD, along with differences in underlying disease, prevented meaningful comparison of morbidity and mortality between PD and PPDD, a significantly shorter median length of stay was observed following PPDD than PD.
Neither crosssectional imaging nor forward viewing endoscopies provide a detailed description of the relationship of the lesion to the papilla. For this reason, patients had consented to PD and selected cases underwent sideviewing ontable endoscopy and duodenotomy/papillary cannulation. The authors would advocate that PPDD should only be undertaken where expertise and facilities support progression to PD.
Eight of the nineteen PPDD undertaken in this 14year period were performed in the last two years. It is likely that this reflects changes in referral patterns to the centre and an increase in the population catchment area, and better awareness of the option of pancreas preservation may have contributed to this increase. This raises the possibility that the technique of PPDD is underused and improved surgical awareness may prevent some patients undergoing unnecessary pancreatic resection with an associated longer hospital stay and likely increased morbidity and mortality.
To the knowledge of the authors, this series brings to 83 the total number of patients undergoing PPDD that have been reported in published literature, which comprises 4 other series and 10 reports of individual cases [3, 8, 9, 1222] . These are summarized in Table 3 .
Represented pathologies include 27 adenocarcinomas of the duodenum (33%), 20 gastrointestinal stromal tumours (24%), 12 adenomas (14%) and 5 trauma (6%) as well as lipoma and liposarcoma, locally invading colon cancer, metastases from seminoma and lung cancer, Crohn's disease, plasmacytoma and lymphoma. Technical variation includes different longitudinal extent of resection and different anastomotic technique with endtoend, endtoside and sidetoside all represented. Three deaths within 30 d of PPDD have been reported; 2 due to cholecystitis and one due to anastomotic leak; giving a periprocedural mortality of 3.7%. Of the 27 patients undergoing PPDD for adenocarcinoma, 10 deaths were recorded and of the 17 patients alive at the time of publication of the individual reports, 7 had survived more than 36 mo. Procedural morbidity included cholangitis/ cholecystitis, anastomotic bleeding, delayed gastric emptying and, unexpectedly, pancreatic fistulae. Overall, morbidity was reported in 32 patients (39%). Laparoscopic [3, 16] and laparoscopicassisted [23] approaches to distal duodenal resection have also been described and may offer patients the expected benefits of minimally invasive surgery.
However, an open approach may be better to achieve adequate assessment and margins for lesions close to the papilla. Concern may exist regarding the oncological effectiveness of PPDD. We suggest that no evidence exists to show benefit of including a pancreatic resection in the treatment of a distal duodenal cancer. This study shows that an adequate lymphadenectomy may be achieved with PPDD (Table 2) . Consistent R0 margin status and adequate histopathological proximal resection margins have been achieved by conversion to PD if intraoperative doubt exists regarding the macroscopic relationship of the disease to surrounding structures. The only pattern of recurrence observed in this series was distant spread to pelvic peritoneum (after resection of T4 lesion with serosal involvement) and the authors propose that there would have been no oncological benefit from the addition of pancreatic head resection. An algorithm describing pre and intraoperative decision making is presented ( Figure 6 ).
PPDD is a valuable technique for the treatment of a wide range of infrapapillary duodenal lesions and an expanding body of published literature exists to support its use. It should be undertaken where expertise and facilities permit conversion to PD if 
COMMENTS
Background
Neoplastic lesions of the duodenum are treated conventionally by pancreaticoduodenectomy. Lesions distal to the major papilla may be suitable for a pancreas-preserving distal duodenectomy (PPDD), potentially reducing morbidity and mortality. Limited awareness of this technique may deprive patients of the opportunity to avoid pancreas-specific complications following treatment for infrapapillary diseases.
Research frontiers
Early series suggested poor outcomes after PPDD for duodenal adenocarcinoma. Adenocarcinoma may thus be considered a contentious indication for PPDD. Figure 6 Flow chart summarising the local algorithm for the management of infrapapillary duodenal lesions. PD: Pancreaticoduodenectomy; PPDD: Pancreas preserving distal duodenectomy.
